Chai Discovery, an artificial intelligence biology startup founded six months ago, has raised nearly $30 million from heavyweights
Chai develops AI foundation models that can predict the structure of biochemical molecules and reprogram how they interact, a process that is central to developing new medications. “We want to turn biology from a science into engineering,” said co-founder and Chief Executive Officer Joshua Meier.
Read the full article here